Published in J Infect Dis on October 01, 1992
Pathogenesis of human immunodeficiency virus infection. Microbiol Rev (1993) 5.88
Mapping of serotype-specific, immunodominant epitopes in the NS-4 region of hepatitis C virus (HCV): use of type-specific peptides to serologically differentiate infections with HCV types 1, 2, and 3. J Clin Microbiol (1993) 2.36
Mother-to-child transmission of human immunodeficiency virus type 1. Epidemiol Rev (1996) 1.08
The affinity of IgG antibodies to gag p24 and p17 in HIV-1-infected patients correlates with disease progression. Clin Exp Immunol (1995) 1.03
Vertical Transmission of HIV-1. Correlation with maternal viral load and plasma levels of CD4 binding site anti-gp120 antibodies. J Clin Invest (1995) 0.96
The role of infant immune responses and genetic factors in preventing HIV-1 acquisition and disease progression. Clin Exp Immunol (2003) 0.95
Human cord blood mononuclear cells are preferentially infected by non-syncytium-inducing, macrophage-tropic human immunodeficiency virus type 1 isolates. J Clin Microbiol (1995) 0.94
Characterization of human immunodeficiency virus type 1 p17 matrix protein motifs associated with mother-to-child transmission. J Virol (1996) 0.91
Pediatric human immunodeficiency virus infection. Clin Microbiol Rev (1996) 0.81
Relationships between humoral factors in HIV-1-infected mothers and the occurrence of HIV infection in their infants. Clin Exp Immunol (1995) 0.79
Pharmacokinetics of hyperimmune anti-human immunodeficiency virus immunoglobulin in persons with AIDS. Antimicrob Agents Chemother (1997) 0.75
Engineering Recombinant Reoviruses To Display gp41 Membrane-Proximal External-Region Epitopes from HIV-1. mSphere (2016) 0.75
Selection for specific sequences in the external envelope protein of human immunodeficiency virus type 1 upon primary infection. J Virol (1993) 6.41
Physical mapping of herpes simplex virus-induced polypeptides. J Virol (1978) 6.08
The human factor: the critical importance of effective teamwork and communication in providing safe care. Qual Saf Health Care (2004) 5.96
Control of protein synthesis in herpesvirus-infected cells: analysis of the polypeptides induced by wild type and sixteen temperature-sensitive mutants of HSV strain 17. J Gen Virol (1976) 5.47
Recombinants between herpes simplex virus types 1 and 2: analyses of genome structures and expression of immediate early polypeptides. J Virol (1978) 4.87
Pooled analysis of prospective cohort studies on height, weight, and breast cancer risk. Am J Epidemiol (2000) 4.83
Alcohol and breast cancer in women: a pooled analysis of cohort studies. JAMA (1998) 4.65
Prevalence of Kaposi's sarcoma associated herpesvirus infection measured by antibodies to recombinant capsid protein and latent immunofluorescence antigen. Lancet (1996) 4.05
A proposed system for the nomenclature of hepatitis C viral genotypes. Hepatology (1994) 4.01
Cohort studies of fat intake and the risk of breast cancer--a pooled analysis. N Engl J Med (1996) 3.79
Classification, nomenclature, and database development for hepatitis C virus (HCV) and related viruses: proposals for standardization. International Committee on Virus Taxonomy. Arch Virol (1998) 3.77
Managing patients with lung cancer. New guidelines should improve standards of care. BMJ (1999) 3.65
Convergent and divergent sequence evolution in the surface envelope glycoprotein of human immunodeficiency virus type 1 within a single infected patient. Proc Natl Acad Sci U S A (1992) 3.58
Mumps meningitis following measles, mumps, and rubella immunisation. Lancet (1989) 3.42
Herpes simplex virus proteins: DNA-binding proteins in infected cells and in the virus structure. Virology (1975) 3.41
Analysis of a new hepatitis C virus type and its phylogenetic relationship to existing variants. J Gen Virol (1992) 3.37
Intake of fruits and vegetables and risk of breast cancer: a pooled analysis of cohort studies. JAMA (2001) 3.37
Anonymous HIV surveillance in Saughton Prison, Edinburgh. AIDS (1992) 3.29
HCV confirmatory testing of blood donors. Lancet (1991) 3.29
Testing of blood donations for hepatitis C virus. Lancet (1994) 3.27
Infection with hepatitis G virus among recipients of plasma products. Lancet (1996) 3.25
Cigarette smoking, N-acetyltransferase 2 genetic polymorphisms, and breast cancer risk. JAMA (1996) 3.18
Survey of major genotypes and subtypes of hepatitis C virus using RFLP of sequences amplified from the 5' non-coding region. J Gen Virol (1995) 3.10
Epidemiological profile and clinical associations of human bocavirus and other human parvoviruses. J Infect Dis (2006) 2.97
Variation of the hepatitis C virus 5' non-coding region: implications for secondary structure, virus detection and typing. The International HCV Collaborative Study Group. J Gen Virol (1995) 2.91
Human cytomegalovirus-specific cytotoxic T cells. Relative frequency of stage-specific CTL recognizing the 72-kD immediate early protein and glycoprotein B expressed by recombinant vaccinia viruses. J Exp Med (1988) 2.73
Studies of behavior change to enhance public health. Am J Public Health (1973) 2.71
Concurrent evolution of human immunodeficiency virus type 1 in patients infected from the same source: rate of sequence change and low frequency of inactivating mutations. J Virol (1990) 2.68
Drug injection and HIV prevalence in inmates of Glenochil prison. BMJ (1995) 2.66
The 65,000-Mr DNA-binding and virion trans-inducing proteins of herpes simplex virus type 1. J Virol (1987) 2.63
Identification of shared populations of human immunodeficiency virus type 1 infecting microglia and tissue macrophages outside the central nervous system. J Virol (2001) 2.62
Hepatitis C virus genotypes: an investigation of type-specific differences in geographic origin and disease. Hepatology (1994) 2.60
Study of infection with HIV and related risk factors in young offenders' institution. BMJ (1993) 2.58
Outbreak of acute hepatitis C following the use of anti-hepatitis C virus--screened intravenous immunoglobulin therapy. Gastroenterology (1996) 2.48
Genetic and biochemical studies with herpesvirus. Cold Spring Harb Symp Quant Biol (1975) 2.47
Clinical significance of intrahepatic hepatitis C virus levels in patients with chronic HCV infection. Gut (1998) 2.45
Mapping of serotype-specific, immunodominant epitopes in the NS-4 region of hepatitis C virus (HCV): use of type-specific peptides to serologically differentiate infections with HCV types 1, 2, and 3. J Clin Microbiol (1993) 2.36
Characterization of the 92,000-dalton glycoprotein induced by herpes simplex virus type 2. J Virol (1984) 2.36
The origin of hepatitis C virus genotypes. J Gen Virol (1997) 2.26
Detection of three types of hepatitis C virus in blood donors: investigation of type-specific differences in serologic reactivity and rate of alanine aminotransferase abnormalities. Transfusion (1993) 2.24
Characteristics of blacks obtaining Papanicolaou smears. Cancer (1976) 2.24
A highly divergent picornavirus in a marine mammal. J Virol (2007) 2.23
Frequent infection of peripheral blood CD8-positive T-lymphocytes with HIV-1. Edinburgh Heterosexual Transmission Study Group. Lancet (1996) 2.20
Production of beta-defensin antimicrobial peptides by the oral mucosa and salivary glands. Infect Immun (1999) 2.19
Prospective randomized trial of docetaxel versus doxorubicin in patients with metastatic breast cancer. J Clin Oncol (1999) 2.19
Use of electric blankets and risk of postmenopausal breast cancer. Am J Epidemiol (1991) 2.17
Outcome for acute bronchitis, bronchiolitis, and pneumonia in infancy. Arch Dis Child (1984) 2.17
Heterosexual spread of human immunodeficiency virus in Edinburgh. Br Med J (Clin Res Ed) (1988) 2.15
Long-term comparison of rituximab treatment for refractory systemic lupus erythematosus and vasculitis: Remission, relapse, and re-treatment. Arthritis Rheum (2006) 2.14
Purification of the herpes simplex virus type 1 65-kilodalton DNA-binding protein: properties of the protein and evidence of its association with the virus-encoded DNA polymerase. J Virol (1988) 2.14
Human cytomegalovirus-specific cytotoxic T cells: their precursor frequency and stage specificity. Eur J Immunol (1988) 2.13
Complete nucleotide sequence of a type 4 hepatitis C virus variant, the predominant genotype in the Middle East. J Gen Virol (1997) 2.13
Virus 'quasispecies': making a mountain out of a molehill? J Gen Virol (1997) 2.07
Identification of the herpes simplex virus protein kinase as the product of viral gene US3. J Gen Virol (1987) 2.06
Diet in the epidemiology of cancer of the colon and rectum. J Natl Cancer Inst (1978) 2.05
HTLV-III antibody in Edinburgh drug addicts. Lancet (1985) 2.03
Investigation of the pattern of hepatitis C virus sequence diversity in different geographical regions: implications for virus classification. The International HCV Collaborative Study Group. J Gen Virol (1995) 2.00
Influence of HAART on HIV-related CNS disease and neuroinflammation. J Neuropathol Exp Neurol (2005) 1.98
No evidence for an association between infections with WU and KI polyomaviruses and respiratory disease. J Clin Virol (2007) 1.96
The molecular epidemiology of human immunodeficiency virus type 1 in Edinburgh. J Infect Dis (1995) 1.94
Effect of autolymphocyte therapy on survival and quality of life in patients with metastatic renal-cell carcinoma. Lancet (1990) 1.94
The prevalence and nature of recent self-reported changes in general dental practice in a sample of English general dental practitioners. Br Dent J (2004) 1.93
Detection, quantification and sequencing of HIV-1 from the plasma of seropositive individuals and from factor VIII concentrates. AIDS (1991) 1.93
Multifocal motor neuropathy with conduction block: is it a distinct clinical entity? Neurology (1992) 1.93
Age-related cognitive deficits, impaired long-term potentiation and reduction in synaptic marker density in mice lacking the beta-amyloid precursor protein. Neuroscience (1999) 1.88
Characteristics of nucleotide substitution in the hepatitis C virus genome: constraints on sequence change in coding regions at both ends of the genome. J Mol Evol (1997) 1.88
Risk of premenopausal breast cancer and use of electric blankets. Am J Epidemiol (1994) 1.85
"What" and "where" in the human auditory system. Proc Natl Acad Sci U S A (2001) 1.84
Identification of the gene encoding the 65-kilodalton DNA-binding protein of herpes simplex virus type 1. J Virol (1988) 1.81
Genetic polymorphisms in catechol-O-methyltransferase, menopausal status, and breast cancer risk. Cancer Res (1998) 1.80
Serological responses to infection with three different types of hepatitis C virus. Lancet (1991) 1.73
The impact of the human immunodeficiency virus type 1 on the management of severe malnutrition in Malawi. Ann Trop Paediatr (2000) 1.73
On the distortion of risk estimates in multiple exposure level case-control studies. Am J Epidemiol (1981) 1.73
Trichomonas vaginalis and cervical cancer. A prospective study in China. Ann Epidemiol (1995) 1.71
Lactation and breast cancer. Evidence for a negative association in premenopausal women. Am J Epidemiol (1985) 1.69
Epidemiology and clinical associations of human parechovirus respiratory infections. J Clin Microbiol (2008) 1.68
Genotype dependence of hepatitis C virus load measurement in commercially available quantitative assays. J Clin Microbiol (1999) 1.68
Confirmation of hepatitis C virus antibody in blood donors. J Med Virol (1993) 1.68
Partial left ventriculectomy to treat end-stage heart disease. Ann Thorac Surg (1997) 1.68
Problem drug use in a central London general practice. BMJ (1992) 1.67
Preconception, intrauterine, and postnatal irradiation as related to leukemia. Natl Cancer Inst Monogr (1966) 1.67
Outcome of acute lower respiratory tract infection in infants: preliminary report of seven-year follow-up study. Br Med J (Clin Res Ed) (1982) 1.66
Heterosexual transmission of hepatitis C virus. Lancet (1993) 1.65
HIV encephalitis, proviral load and dementia in drug users and homosexuals with AIDS. Effect of neocortical involvement. Brain (1998) 1.65
The product of gene US11 of herpes simplex virus type 1 is expressed as a true late gene. J Gen Virol (1986) 1.63
Familial breast cancer: an investigation into the outcome of treatment for early stage disease. Fam Cancer (2001) 1.62
Five year follow-up of a smoking withdrawal clinic population. Am J Public Health (1977) 1.62
Processing of herpes simplex virus proteins and evidence that translation of thymidine kinase mRNA is initiated at three separate AUG codons. J Virol (1983) 1.62
Detailed mapping of RNA secondary structures in core and NS5B-encoding region sequences of hepatitis C virus by RNase cleavage and novel bioinformatic prediction methods. J Gen Virol (2004) 1.62
Two-dimensional gel analysis of HSV type 1-induced polypeptides and glycoprotein processing. J Gen Virol (1981) 1.61
HIV-1 tropism and co-receptor use. Nature (1997) 1.60
Irradiation in the epidemiology of leukemia among adults. J Natl Cancer Inst (1972) 1.59
Symptoms, atopy, and bronchial reactivity after lower respiratory infection in infancy. Arch Dis Child (1984) 1.59
Manganese superoxide dismutase (MnSOD) genetic polymorphisms, dietary antioxidants, and risk of breast cancer. Cancer Res (1999) 1.57
Distribution of hepatitis C virus genotypes determined by line probe assay in patients with chronic hepatitis C seen at tertiary referral centers in the United States. Hepatitis Interventional Therapy Group. Ann Intern Med (1996) 1.56
Hepatitis C virus (HCV) genotypes and chronic liver disease in Pakistan. J Gastroenterol Hepatol (1997) 1.55
First coitus before menarche and risk of sexually transmitted disease. Lancet (1990) 1.55
Molecular investigation of human immunodeficiency virus (HIV) infection in a patient of an HIV-infected surgeon. J Infect Dis (1993) 1.54
Molecular epidemiology of an outbreak of infection with hepatitis C virus in recipients of anti-D immunoglobulin. Lancet (1995) 1.54